Key result
Acute respiratory infections linked to ~6-fold higher short-term MI risk, led by early influenza.
Why the study?
This narrative review evaluated associations between bacterial and viral infections and MI or ACS, with attention to event timing, coronary outcome definitions, and MI subtype.
Are bacterial and viral infections associated with an increased short-term or long-term risk of acute myocardial infarction or acute coronary syndrome in adults?
Are bacterial and viral infections associated with an increased short-term or long-term risk of acute myocardial infarction or acute coronary syndrome in adults?
This narrative review demonstrates consistent short-term elevations in acute myocardial infarction risk during the first week after acute respiratory, influenza, COVID-19, bloodstream, and urinary tract infections, as well as longer-term elevated risks in HIV, tuberculosis, and post-acute COVID-19, supporting clinical awareness of recent infection when evaluating new ischemic symptoms while emphasizing that observational data do not justify routine cardiac testing or antithrombotic therapy based on infection alone.
Answers are grounded in this paper and cite their sources.
Supports considering recent infection in new ischemic symptoms; leaves open whether targeted interventions reduce MI risk.
This narrative review evaluates associations between bacterial and viral infections and myocardial infarction (MI) or acute coronary syndrome (ACS), with attention to event timing, coronary outcome definitions, and MI subtype. PubMed/MEDLINE and Embase were searched on October 6, 2026. The non-exhaustive narrative inventory comprises 44 selected original studies, including 41 primary association studies and three complementary studies of broader outcomes, prognosis, or classification. Findings were synthesized qualitatively according to infection, study design, comparator, and risk window. The MI-specific outcomes were considered separately from ACS and broader cardiovascular composites, and study limitations informed the interpretation of individual findings. No pooled effect was calculated. Across the selected evidence, the clearest short-term pattern was an increase in coronary events during the first days after respiratory infection and laboratory-confirmed influenza. Early associations were also reported after COVID-19, bloodstream infection, and urinary tract infection (UTI). Estimates varied with infection severity, comparator selection, and the handling of events diagnosed on the same day as infection. Post-acute COVID-19, HIV, and tuberculosis studies described associations over longer follow-up, whereas the limited MI-specific hepatitis C evidence did not demonstrate a statistically significant association. These longer-term findings addressed a different question from acute triggering and could not establish a shared mechanism. Residual confounding, overlapping populations, outcome misclassification, and incomplete MI subtype information limited interpretation. Most studies did not establish whether coronary events reflected type 1 MI, type 2 MI, or another process, and myocardial injury during infection could not be assumed to represent ischemic MI. Overall, the review supports considering recent infection when evaluating new ischemic symptoms while interpreting the evidence in relation to the population, endpoint, and time window studied. The observational associations do not establish causation or support routine cardiac testing or antithrombotic treatment based on infection alone. Further studies should distinguish MI subtypes and report absolute as well as relative risks.
No takes yet. Share an insight, caveat, or question.
Lopez et al. (2026) conducted a review in Bacterial and viral infections in relation to acute myocardial infarction or acute coronary syndrome. Bacterial and viral infections (influenza, COVID-19, bloodstream infection, UTI, HIV, tuberculosis, hepatitis C) vs. Uninfected external controls or within-person reference periods was evaluated on Myocardial infarction or acute coronary syndrome (qualitative synthesis across 44 studies; no pooled effect calculated). Acute respiratory, influenza, COVID-19, and bacterial infections increased short-term MI risk, while HIV and tuberculosis showed longer-term associations.
Synapse has enriched 10 related papers. Consider them for comparative context: